Table 4.
Model | variable | HR(95% CI) | P value |
---|---|---|---|
rs1990172 | |||
Dominant | GT&TT genotype | 1.80(1.14-2.85) | 0.011 |
Tumor size>5cm | 2.46(1.58-3.83) | <0.001 | |
AFP >400 ng/mL | 1.83(1.17-2.88) | 0.009 | |
PVTT | 2.44(1.59-3.75) | <0.001 | |
Overdominant | GT genotype | 2.27(1.41-3.66) | 0.001 |
Tumor size>5cm | 2.30(1.47-3.61) | <0.001 | |
AFP >400 ng/mL | 1.95(1.24-3.07) | 0.004 | |
PVTT | 2.50(1.62-3.85) | <0.001 | |
rs975263 | |||
Dominant | CT&CC genotype | 1.69(1.09-2.63) | 0.02 |
Tumor size>5cm | 2.58(1.65-4.03) | <0.001 | |
AFP >400 ng/mL | 1.83(1.16-2.88) | 0.01 | |
PVTT | 2.36(1.54-3.63) | <0.001 | |
Overdominant | CT genotype | 2.16(1.37-3.39) | 0.001 |
Tumor size>5cm | 2.49(1.59-3.90) | <0.001 | |
AFP >400 ng/mL | 1.94(1.23-3.07) | 0.004 | |
PVTT | 2.41(1.56-3.72) | <0.001 |
AFP, α-fetoprotein; PVTT, portal vein tumor thrombi; HR, hazard ratio; CI, confidence interval.